AmyriAD Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Angel

  • Investors
  • 3

AmyriAD General Information

Description

Operator of a clinical-stage biopharmaceutical company intended to develop therapies for Alzheimer's disease. The company engages in developing a drug that is an orally administered small molecule treatment that enhances neurotransmission in the brain and improves both cognition and independent global function, enabling medical practitioners to use neurotransmission and improve both cognition and independent global function.

Contact Information

Formerly Known As
Leszath Pharmaceuticals
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 21370 South West Langer Farms Parkway
  • Suite 142-114
  • Sherwood, OR 97140
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 21370 South West Langer Farms Parkway
  • Suite 142-114
  • Sherwood, OR 97140
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AmyriAD Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Angel (individual) 01-Jan-2024 Completed Clinical Trials - Phase 3
3. Early Stage VC 10-Jun-2022 Completed Clinical Trials - Phase 3
2. Early Stage VC (Series A) 27-Nov-2020 Completed Clinical Trials - Phase 3
1. Seed Round 20-Dec-2019 Completed Clinical Trials - Phase 3
To view AmyriAD’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

AmyriAD Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a clinical-stage biopharmaceutical company intended to develop therapies for Alzheimer's disease. The compan
Drug Discovery
Sherwood, OR
6 As of 2026

Framingham, MA
 

Watertown, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AmyriAD Competitors (6)

One of AmyriAD’s 6 competitors is Alzheon, a Venture Capital-Backed company based in Framingham, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Alzheon Venture Capital-Backed Framingham, MA
Neumora Formerly VC-backed Watertown, MA
Prothena Corporation Dublin, Ireland
Acumen Pharmaceuticals Formerly VC-backed Newton, MA
Altos Labs Private Equity-Backed Redwood City, CA
To view AmyriAD’s complete competitors history, request access »

AmyriAD Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AmyriAD Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Frühstarter Ventures Angel Group Minority
Korify Capital Venture Capital Minority
Stern Stewart Ventures Corporate Venture Capital Minority
To view AmyriAD’s complete investors history, request access »

AmyriAD Acquisitions (1)

AmyriAD’s most recent deal was a Merger/Acquisition with Recognify Life Sciences. The deal was made on 07-Oct-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Recognify Life Sciences 07-Oct-2026 Merger/Acquisition Drug Discovery
To view AmyriAD’s complete acquisitions history, request access »

AmyriAD Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Recognify Life Sciences Berlin, Germany 2018

AmyriAD FAQs

  • When was AmyriAD founded?

    AmyriAD was founded in 2019.

  • Where is AmyriAD headquartered?

    AmyriAD is headquartered in Sherwood, OR.

  • What is the size of AmyriAD?

    AmyriAD has 6 total employees.

  • What industry is AmyriAD in?

    AmyriAD’s primary industry is Drug Discovery.

  • Is AmyriAD a private or public company?

    AmyriAD is a Private company.

  • What is AmyriAD’s current revenue?

    The current revenue for AmyriAD is .

  • How much funding has AmyriAD raised over time?

    AmyriAD has raised $404K.

  • Who are AmyriAD’s investors?

    Frühstarter Ventures, Korify Capital, and Stern Stewart Ventures have invested in AmyriAD.

  • Who are AmyriAD’s competitors?

    Alzheon, Neumora, Prothena, Acumen Pharmaceuticals, and Altos Labs are some of the 6 competitors of AmyriAD.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process